Blog

Exclusive: Americans overpaying hugely for cancer drugs – academic study

Americans are paying way over the odds for some modern cancer drugs, with pharmaceutical companies charging up to 600 times what the medicines cost to make, according to an independent academic study. The United States also pays more than double the price charged in Europe for these drugs – so-called tyrosine kinase inhibitors (TKIs), a potent class of cancer pills with fewer side effects than chemotherapy.     The analysis by pharmacologist

How Medicare’s 'chronic care management' payments could affect primary care

By Will Boggs MD (Reuters Health) – Medicare’s new “chronic care management” (CCM) payment program could make it more financially feasible for physicians to deliver services between visits. Under the new program, Medicare could reimburse primary care practices about $40 month for such things as medication management and communication with other doctors for patients who have two or more chronic medical conditions. CCM has the potential to organize the coordination

Verse team face Leger appeal

The disciplinary panel of the British Horseracing Authority will on Wednesday hear the appeal by connections of Simple Verse against the decision to demote the filly from first place in the Ladbrokes St Leger at Doncaster.